Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Ferro

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Case Reports in Hematology|September 1, 2012
Cytogenetics findings in a histiocytic sarcoma caseJ M Alonso-Dominguez, M Calbacho, M Talavera, et al.
Bone Marrow Transplantation|April 1, 1999
Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantationJ L Steegmann, L F Casado, J F Tomás, et al.
Haematologica|December 20, 1999
Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha2a and CMLJ L Steegmann, J Odriozola, F Rodriguez-Salvanés, et al.
Haematologica|August 28, 2001
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMAJ M Hernández, G Martín, N C Gutiérrez, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Case Reports in Hematology|September 1, 2012
Cytogenetics findings in a histiocytic sarcoma caseJ M Alonso-Dominguez, M Calbacho, M Talavera, et al.
Bone Marrow Transplantation|April 1, 1999
Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantationJ L Steegmann, L F Casado, J F Tomás, et al.
Haematologica|December 20, 1999
Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha2a and CMLJ L Steegmann, J Odriozola, F Rodriguez-Salvanés, et al.
Haematologica|August 28, 2001
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMAJ M Hernández, G Martín, N C Gutiérrez, et al.
Pageof 6